305 related articles for article (PubMed ID: 27219622)
1. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
[TBL] [Abstract][Full Text] [Related]
2. Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.
van Ravenhorst MB; den Hartog G; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
PLoS One; 2018; 13(4):e0191261. PubMed ID: 29672552
[TBL] [Abstract][Full Text] [Related]
3. Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.
Stoof SP; van der Klis FR; van Rooijen DM; Bogaert D; Trzciński K; Sanders EA; Berbers GA
Vaccine; 2015 Jul; 33(32):3933-9. PubMed ID: 26100925
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
Khalil M; Al-Mazrou Y; Findlow H; Chadha H; Bosch Castells V; Oster P; Borrow R
Vaccine; 2014 Sep; 32(43):5715-21. PubMed ID: 25151042
[TBL] [Abstract][Full Text] [Related]
5. Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
BMC Med Res Methodol; 2019 Jan; 19(1):1. PubMed ID: 30611213
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents.
Zhang Q; Choo S; Everard J; Jennings R; Finn A
Infect Immun; 2000 May; 68(5):2692-7. PubMed ID: 10768961
[TBL] [Abstract][Full Text] [Related]
7. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants.
Zhang Q; Pettitt E; Burkinshaw R; Race G; Shaw L; Finn A
Pediatr Infect Dis J; 2002 Mar; 21(3):209-13. PubMed ID: 12005084
[TBL] [Abstract][Full Text] [Related]
9. Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides.
Bårnes GK; Kristiansen PA; Caugant DA; Næss LM
Clin Vaccine Immunol; 2015 Jul; 22(7):697-705. PubMed ID: 25924767
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
12. The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.
Dbaibo G; Van der Wielen M; Reda M; Medlej F; Tabet C; Boutriau D; Sumbul A; Anis S; Miller JM
Int J Infect Dis; 2012 Aug; 16(8):e608-15. PubMed ID: 22704725
[TBL] [Abstract][Full Text] [Related]
13. Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine.
Borrow R; Fox AJ; Cartwright K; Begg NT; Jones DM
Epidemiol Infect; 1999 Oct; 123(2):201-8. PubMed ID: 10579438
[TBL] [Abstract][Full Text] [Related]
14. Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?
Stoof SP; Buisman AM; van Rooijen DM; Boonacker R; van der Klis FR; Sanders EA; Berbers GA
PLoS One; 2015; 10(10):e0138665. PubMed ID: 26458006
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan.
Huo Z; Sinha R; McNeela EA; Borrow R; Giemza R; Cosgrove C; Heath PT; Mills KH; Rappuoli R; Griffin GE; Lewis DJ
Infect Immun; 2005 Dec; 73(12):8256-65. PubMed ID: 16299322
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for the prevention of meningococcal disease in children.
Soriano-Gabarró M; Stuart JM; Rosenstein NE
Semin Pediatr Infect Dis; 2002 Jul; 13(3):182-9. PubMed ID: 12199614
[TBL] [Abstract][Full Text] [Related]
17. Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination.
Perrett KP; Richmond PC; Borrow R; Nolan T; McVernon J
Pediatr Infect Dis J; 2015 Mar; 34(3):279-85. PubMed ID: 25742078
[TBL] [Abstract][Full Text] [Related]
18. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
[TBL] [Abstract][Full Text] [Related]
20. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
